PRLD - Prelude Therapeutics Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$8.00
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
72.41%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 16,329 | $55,845 | 0.0% | -42,839 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-09 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | A-Award | 38,000 | $3.94 | $150K |
| 2026-06-09 | Dorton Katina | director | A-Award | 38,000 | $3.94 | $150K |
| 2026-06-09 | Babler Martin | director | A-Award | 38,000 | $3.94 | $150K |
| 2026-06-09 | Bonita David P | director, 10 percent owner: | A-Award | 38,000 | $3.94 | $150K |
| 2026-06-09 | Sandor Victor | director | A-Award | 38,000 | $3.94 | $150K |
| 2026-06-09 | FRIEDMAN PAUL A | director | A-Award | 38,000 | $3.94 | $150K |
| 2026-05-01 | Morris Charles Q | officer: Chief Medical Officer | A-Award | 450,000 | $4.70 | $2.1M |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | 1,407,000 | $0.00 | $140 |
| 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | ? | -- | -- | -- |
| 2026-04-21 | Bonita David P | director, 10 percent owner: | BUY | 1,126,126 | $4.44 | $5.0M |
| 2026-04-21 | ORBIMED ADVISORS LLC | director, 10 percent owner: | BUY | 1,689,189 | $4.44 | $7.5M |
| 2026-04-21 | Bonita David P | director, 10 percent owner: | BUY | 1,689,189 | $4.44 | $7.5M |
| 2026-04-21 | ORBIMED ADVISORS LLC | director, 10 percent owner: | BUY | 1,126,126 | $4.44 | $5.0M |
| 2026-04-21 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | BUY | 2,137,651 | $0.00 | $213 |
| 2026-04-21 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | BUY | 114,601 | $0.00 | $11 |
| 2026-04-15 | Morris Charles Q | ? | -- | -- | -- | |
| 2026-03-05 | Brusky Sean P. | officer: Chief Business Officer | ? | -- | -- | -- |
| 2026-03-05 | Brusky Sean P. | officer: Chief Business Officer | ? | 275,000 | -- | -- |
| 2026-02-04 | Vaddi Krishna | director, officer: CEO | A-Award | 837,000 | $2.30 | $1.9M |
| 2026-02-04 | Combs Andrew | officer: Chief Chemistry Officer | A-Award | 230,000 | $2.30 | $529K |
| 2026-02-04 | Scherle Peggy | officer: Chief Scientific Officer | A-Award | 230,000 | $2.30 | $529K |
| 2026-02-04 | Lim Bryant David | officer: CLO, CFO, Corp Sec. | A-Award | 275,000 | $2.30 | $632K |
| 2025-11-05 | Sandor Victor | director | A-Award | 121,285 | $1.39 | $169K |
| 2025-10-17 | Dorton Katina | ? | -- | -- | -- | |
| 2025-10-04 | Huang Jane | officer: President, CMO | M-Exempt | 9,375 | -- | -- |